Pharmacotherapy 37 , 927943 (2017)
131 Additionally, somatostatin is also produced by endocrine cells in the central nervous system (resulting in decreased growth hormone secretion) and the GIT (resulting in slowed digestion)
Myth: More ingredients = better results. Fact: More ingredients can also mean more variables (tolerability, interactions, unclear dosing)
Microdosing GLP-1 helps calm appetite spikes, stabilize insulin response, and make body recomposition feel a bit more achievable without the heavy side effects that come with full medical doses
Medications like orforglipron (an oral, non-peptide GLP-1 agonist), survodutide (a dual glucagon/GLP-1 agonist), and CagriSema (combining cagrilintide with semaglutide) are advancing through clinical trials
However, some products may be eligible for FSA or HSA reimbursement